These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2896505)

  • 21. [Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (3). General pharmacological actions (author's transl)].
    Sato M; Ishizuka Y; Tanizawa H; Fukuda T; Yuizono T
    Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):291-307. PubMed ID: 317064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of suriclone, a benzodiazepine receptor agonist.
    Codding PW; Szkaradzinska MB; Duke NE
    Acta Crystallogr C; 1988 Nov; 44 ( Pt 11)():1938-42. PubMed ID: 2908380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [General pharmacological studies on pepleomycin sulfate (NK 631) (author's transl)].
    Ishii Y; Furuta Y; Adachi K; Fujii Y; Nakamura K; Itoh S; Saitoh K; Terada M; Watanabe H
    Jpn J Antibiot; 1978 Dec; 31(12):910-21. PubMed ID: 83413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of CN-100 (2-(10,11-dihydro-10-oxodibenzo [b,f] thiepin-2-yl) propionic acid) on cardiovascular and autonomic nervous function in the dog and guinea pig].
    Kushiku K; Abe M; Morishita H; Furukawa T
    Nihon Yakurigaku Zasshi; 1989 Nov; 94(5):299-307. PubMed ID: 2613109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
    Shibata K; Mita I; Shinoda Y; Nakano U; Kinoshita H; Noguchi M; Uzawa T; Sohmiya Y; Takayanagi N
    Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of 1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol and possible mechanisms involved.
    Kushiku K; Ohba M; Araki T; Mikagi T; Katsuragi T; Furukawa T
    Arzneimittelforschung; 1989 Apr; 39(4):458-63. PubMed ID: 2751731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
    Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of suriclone with central type benzodiazepine receptors in living baboons.
    Brouillet E; Chavoix C; Hantraye P; Kunimoto M; Khalili-Varasteh M; Chevalier P; Frydman A; Gaillot J; Prenant C; Crouzel M
    Eur J Pharmacol; 1990 Jan; 175(1):49-55. PubMed ID: 1969798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
    Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
    Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
    Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
    Nakamura T; Miura Y; Aihara K; Satoh H; Goto K; Tsumagari T
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological study of prolinomethyltetracycline].
    Koeda T; Shibata U; Nakazawa T; Asaoka H
    Jpn J Antibiot; 1971 Dec; 24(6):256-64. PubMed ID: 5316823
    [No Abstract]   [Full Text] [Related]  

  • 39. [General pharmacology of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic].
    Tone H; Kiyosaki T; Nishimori T; Kobayashi F; Nishimura K; Morino H; Tsuchiyama M
    Jpn J Antibiot; 1986 Feb; 39(2):526-46. PubMed ID: 3712756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General pharmacology of recombinant human tumor necrosis factor. 1st communication: effects on cardiovascular, gastrointestinal, renal and blood functions.
    Nakatsuji K; Kii Y; Fujitani B; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):218-25. PubMed ID: 2334464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.